期刊文献+

等渗与低渗盐水防治造影剂肾病的效果比较 被引量:7

Comparative study on the effect of isotonic and hypotonic sodium chloride solution in prevention of CIN in patients undergoing cardio angioplasty
下载PDF
导出
摘要 目的比较等渗(0.9%氯化钠水溶液)与低渗(0.45%氯化钠水溶液)盐水对心脏介入术所导致的造影剂肾病(CIN)的防治效果。方法将184例接受心脏介入术的患者随机分为A、B两组,于术前12h至术后12h分别静脉滴注低渗与等渗盐水,观察两组造影剂肾病的发病例数、术前1d、术后24、48h及第7d血清肌酐(SCr)、肌酐清除率(CCr)的变化,记录造影剂的用量。结果B组(等渗)较A组(低渗)CIN的发生例数明显减少,无合并症的患者无一例发生CIN,有单一合并症者两组间CIN发生率无统计学差异。结论为防治心脏介入诊疗术中造影剂肾病(CIN)的发生,在围手术期应用等渗盐水较低渗盐水效果更好。 Objective To evaluate the efficacy of 2 types of hydration regimens in the patients undergoing cardioangioplasty in the prevention of contrast medium induced nephropathy(CIN). Methods 184 patients undergoing cardio angioplasty were randomly divided into 2 groups : A and B. The patients in group A were treated with intravenous drip of 0. 45% NaCl solution and group B with 0. 9% NaCl solution during 12 hours before and after operation. The dose of contrast medium was recorded. The level of serum creatinine ( SCr), ereatinine clearance (CCr) 1 day before and 24, 48 hours, 7 days after coronary angioplasty and the number of patients developing CIN in both groups were observed. Results The number of CIN cases in goup B was much less than that in group A( P 〈 0. 05 ). There was no cases of CIN in the patients without risk factors( renal dysfunction, hypertention, diabetes, heart failure, et al). There was no statistic difference between the two groups in the patients with risk factors. Conclusion To prevent CIN, the transfusion of 0. 9% NaCl solution is better than 0. 45% NaCl solution in the patients undergoing cardio angiopasty in perioprative period
出处 《海南医学》 CAS 2009年第3期16-18,共3页 Hainan Medical Journal
关键词 造影剂肾病 等渗盐水 低渗盐水 心脏 Contrast medium induced nephropathy Isotonic saline solution Hypotonie saline chloride solution Heart
  • 相关文献

参考文献11

  • 1Briguori C, Airoldi F. Morici N, et al. New pharmacological protocols to prevent or reduce contrast media nephropathy[ J ]. Minerva Cardioangiol, 2005,53 ( 1 ) : 49 - 58.
  • 2Dangas G, Inkovou I, Nikolsky E, et al. Contrast -induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables[ J]. Am J Cardiol, 2005,95: 13 - 19.
  • 3Kay J, Chow WH, Chan TM, et al. Acetylcysteine for prevention of acute deterioration of renal function following elective coronary angiography and intervention : a randomized controlled trial [ J ]. JAMA, 2003,289: 553 -558.
  • 4Mueller C. Buerkle G, Buettner HJ, et al. Prevention of contrast media- associated nephropathy[ J]. Arch Intern Med, 2002,162: 329 - 336.
  • 5Nikolsky E, Aymong ED, Dangas G. et al. Radiocontrast nephropathy: identifying the high risk patient and the implications exacerbating renal function[ J], Rev Cardiovasc Med, 2003,4 ( 1 ) : 7 - 14.
  • 6Rihal CS, Textor SC, Grill DE, et al. Incidence and prognostic importance of acute renal failure after pereutaneous coronary intervention [ J ]. Circulation, 2002,105 (19) : 2259 - 2264.
  • 7Cigarroa RG, LongeRA, Williams RH, et al. Dosing of contrast material to prevent contrast. Nephropathy in patient with renal disease. Am J Med, 1989,86: 649 - 652.
  • 8Manske CL, Sprafka JM, Strong, et al. Contrast nephropathy in azotemic diabetic patients undergoing coronary angiography. Am J Med, 1990,89:615 -620.
  • 9Christian M, Gerd B, Heinz B, Prevention of contrast media associated nephropathy. Arch Intern Med, 2002, 162 ( 3 ) : 329-336.
  • 10Diaz - Sandoval LJ, Kosowsky BD, Losordo DW. Acetylcysteine to prevent angiography -related renal tissue injury[ J]. Am J Cardiol, 2002,89: 356.

同被引文献55

引证文献7

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部